Pharma Industry News Weekly Recap: November 18, 2022

2022-11-18T10:59:39-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Adamis, Harpoon, Neoleukin and Tricida add to biotech layoff wave as pipeline setbacks [...]

Pharma Industry News Weekly Recap: November 11, 2022

2022-11-11T09:25:35-07:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Early data hint at benefit for Amgen’s obesity drug November 8, 2022 / [...]

Pharma Industry News Weekly Recap: September 9, 2022

2022-09-16T11:20:00-07:00AI, Blockchain, Cancer, Cardiovascular, COVID-19, Diabetes, Digital Health, Drug Discovery, FDA, Insulin, Medical Marijuana, Mergers, Mobile Apps, Neuroscience, Obesity, Oncology, Wearables, Women's Health|

// Biotech and Pharma Therapeutics Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals September [...]

Pharma Industry News Weekly Recap: August 18, 2022

2022-08-19T13:51:08-07:004IR, AI, Alzheimer's, Antibody Treatments, Biden, Biopharmaceutical Product Development, Cancer, Cardiovascular, Cell Therapy, CNS, COVID-19, Diabetes, Digital Innovation, FDA, Gene Therapy, Heart Failure, Industry News, Medical Marijuana, Neuroscience, Obesity, Oncology, Politics, Private Equity & Venture Capital, Regulatory, Research, Women's Health|

// Biotech and Pharma Therapeutics CRISPR offers genetic clues to Alzheimer's in brain's cleaning crew August 16, 2022 / [...]

Go to Top